New-onset persistent LBBB following TAVR increased the risk of cardiovascular mortality or heart failure hospitalization compared to no NOP-LBBB (37.5% vs 31.5%; aHR 1.37; 95% CI 1.09-1.73; P=0.007).
Cohort (n=1,052)
Does new-onset persistent left bundle branch block following TAVR increase the risk of cardiovascular mortality or heart failure hospitalization in patients without preprocedural LBBB or permanent pacemaker?
New-onset persistent LBBB following TAVR is associated with significantly increased long-term risks of cardiovascular mortality, sudden death, and progressive left ventricular dysfunction.
Hazard Ratio: 1.37 (95% CI 1.09–1.73)
Absolute Event Rate: 37.5% vs 31.5%
p-value: p=0.007
BACKGROUND: New-onset persistent left bundle branch block (NOP-LBBB) is a frequent conduction disturbance following transcatheter aortic valve replacement (TAVR), yet its long-term prognostic significance remains uncertain. OBJECTIVES: The aim of this study was to assess the impact of NOP-LBBB on long-term (up to 10 years) clinical and echocardiographic outcomes after TAVR. METHODS: A total of 1,052 consecutive patients without preprocedural LBBB or permanent pacemaker implantation were included. NOP-LBBB was defined as new LBBB following TAVR persisting at discharge. Clinical and echocardiographic outcomes were prospectively collected in a dedicated database, and the median follow-up duration was 5 years (Q1-Q3: 3-6 years). RESULTS: NOP-LBBB occurred in 312 patients (29.6%). Compared with patients without NOP-LBBB, those with NOP-LBBB had a higher incidence of the composite endpoint of cardiovascular mortality or heart failure hospitalization (37.5% vs 31.5%; adjusted HR aHR: 1.37; 95% CI: 1.09-1.73; P = 0.007). This difference was driven primarily by an increased cardiovascular mortality risk (30.5% vs 23.8%; aHR: 1.46; 95% CI: 1.12-1.89; P = 0.004), including a higher rate of sudden death in the NOP-LBBB group (4.2% vs 1.5%, aHR: 3.52; 95% CI: 1.53-8.14; P = 0.003). A higher incidence of left ventricular ejection fraction decline (≥10%) was observed in the NOP-LBBB group (P = 0.025) with no differences in heart failure hospitalization between groups (P = 0.243). CONCLUSIONS: NOP-LBBB following TAVR was associated with adverse long-term outcomes, including cardiovascular mortality, sudden death, and progressive left ventricular dysfunction. These findings underscore the need for tailored follow-up and risk stratification in this high-risk subgroup.
Benavent-Garcia et al. (Fri,) conducted a cohort in New-onset persistent left bundle branch block following TAVR (n=1,052). New-onset persistent left bundle branch block (NOP-LBBB) vs. Patients without NOP-LBBB was evaluated on Composite endpoint of cardiovascular mortality or heart failure hospitalization (aHR 1.37, 95% CI 1.09-1.73, p=0.007). New-onset persistent LBBB following TAVR increased the risk of cardiovascular mortality or heart failure hospitalization compared to no NOP-LBBB (37.5% vs 31.5%; aHR 1.37; 95% CI 1.09-1.73; P=0.007).